{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:33:32Z","timestamp":1776123212088,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jcms.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T12:17:41Z","timestamp":1492517861000},"page":"1251-1257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cytoprotective effects of melatonin on zoledronic acid-treated human osteoblasts"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-1792","authenticated-orcid":false,"given":"F.","family":"Camacho-Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Urrutia-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"O\u00f1ate-Cabrerizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.","family":"O\u00f1ate-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-740X","authenticated-orcid":false,"given":"F.J.","family":"Rodr\u00edguez-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2017.04.006_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2017.04.006_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.060107","article-title":"Osteocyte apoptosis induced by weightlessness in mice and precedes osteoclasts recruitment and bone loss","volume":"21","author":"Aguirre","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.04.006_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00784-015-1528-y","article-title":"PRGF exerts a cytoprotective role in zoledronic acid-treated cells","volume":"20","author":"Anitua","year":"2016","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2017.04.006_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.oraloncology.2008.05.011","article-title":"Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification","volume":"45","author":"Bagan","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2017.04.006_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.oraloncology.2009.01.002","article-title":"Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update","volume":"45","author":"Bagan","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2017.04.006_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S8756-3282(01)00412-4","article-title":"Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts","volume":"28","author":"Benford","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2017.04.006_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1196\/annals.1402.018","article-title":"Osteocytes as dynamic multifunctional cells","volume":"1116","author":"Bonewald","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcms.2017.04.006_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2017.04.006_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","article-title":"Osteogenesis imperfect: update on presentation and management","volume":"9","author":"Cheung","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jcms.2017.04.006_bib9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","article-title":"Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298","volume":"15","author":"Coxon","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.jcms.2017.04.006_bib10","first-page":"5","article-title":"Melatonin and its role in oxidative stress related diseases of oral cavity","volume":"58","author":"Czeniskiewiz-Guik","year":"2007","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jcms.2017.04.006_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mad.2011.10.005","article-title":"Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model","volume":"132","author":"Cuesta","year":"2011","journal-title":"Mech Ageing Dev"},{"issue":"2 Suppl 6","key":"10.1016\/j.jcms.2017.04.006_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0093-7754(01)90259-3","article-title":"Chemical and biological prerequisites for novel bisphosphonate molecules: results of comparative preclinical studies","volume":"28","author":"Green","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcms.2017.04.006_bib13","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1746-160X-6-12","article-title":"The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in\u00a0vitro","volume":"6","author":"Koch","year":"2010","journal-title":"Head Face Med"},{"key":"10.1016\/j.jcms.2017.04.006_bib15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1359\/jbmr.2002.17.7.1219","article-title":"Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation","volume":"17","author":"Koyama","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.04.006_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-079X.2010.00832.x","article-title":"Melatonin delays cell proliferation by inducing G1 and G2\/M phase arrest in a human osteoblastic cell line hFOB 1.19","volume":"50","author":"Liu","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1016\/j.jcms.2017.04.006_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jpi.12133","article-title":"Melatonin regulates mesenchymal stem cell differentiation: a review","volume":"56","author":"Luchetti","year":"2014","journal-title":"J\u00a0Pineal Res"},{"key":"10.1016\/j.jcms.2017.04.006_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0093-7754(01)90261-1","article-title":"Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program","volume":"28","author":"Major","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcms.2017.04.006_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","article-title":"Sinus tracts \u2013 an early sign of bisphosphonate-associated osteonecrosis of the jaws?","volume":"67","author":"Mawardi","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib22","doi-asserted-by":"crossref","first-page":"PL271","DOI":"10.1016\/0024-3205(94)00666-0","article-title":"Melatonin: a peroxyl radical scavenger more effective than vitamin E","volume":"55","author":"Pieri","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.jcms.2017.04.006_bib23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.jcms.2017.04.006_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bone.2006.02.060","article-title":"Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts\/osteocytes with novel analogs","volume":"39","author":"Plotkin","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2017.04.006_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-079X.2006.00318.x","article-title":"Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK\/ERK (1\/2) signaling cascade","volume":"40","author":"Radio","year":"2006","journal-title":"J\u00a0Pineal Res"},{"key":"10.1016\/j.jcms.2017.04.006_bib26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jcms.2015.04.012","article-title":"Cytoprotective effect of melatonin on zoledronic acid-treated human mesenchymal stem cells in\u00a0vitro","volume":"43","author":"Rodr\u00edguez-Lozano","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib27","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jcms.2017.04.006_bib28","doi-asserted-by":"crossref","first-page":"22041","DOI":"10.1074\/jbc.274.31.22041","article-title":"Melatonin promotes osteoblast differentiation and bone formation","volume":"274","author":"Roth","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcms.2017.04.006_bib37","first-page":"2","article-title":"American Association of Oral and Maxillofaial Surgeons position paper on bisphosphonated-related osteonecrosis of tha jaw--2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication \u2013related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.04.006_bib31","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.3390\/ijms160816981","article-title":"Evaluating the oxidative stress in inflammation: role of melatonin","volume":"16","author":"S\u00e1nchez","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcms.2017.04.006_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-079X.2006.00410.x","article-title":"Melatonin at pharmacological doses enhances human osteoblastic differentiation in\u00a0vitro and promotes mouse cortical bone formation in vivo","volume":"42","author":"Satomura","year":"2007","journal-title":"J Pineal Res"},{"key":"10.1016\/j.jcms.2017.04.006_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/hed.20941","article-title":"Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws","volume":"31","author":"Stumpe","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.jcms.2017.04.006_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","article-title":"Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in\u00a0vitro","volume":"17","author":"Walter","year":"2011","journal-title":"Oral Dis"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518217301385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518217301385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:37:43Z","timestamp":1760884663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518217301385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1010518217301385"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2017.04.006","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoprotective effects of melatonin on zoledronic acid-treated human osteoblasts","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}